Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

Nav

General Info

Geography

Argentina (ARG)

Australia (AUS)

Austria (AUT)

Belgium (BEL)

Brazil (BRA)

View all

Time period covered

01/2001 - 12/2008

Data type

Scientific literature

Keywords

Blood pressure, Ischemic heart disease, Stroke

Citation

Authors

Journal

Lancet

Volume

372

Issue

9644

Pages

1174–83

Publication year

2008

Suggested citation

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008; 372(9644): 1174–83.

GHDx Entry last modified on: Oct 24, 2024

Header sites

Search form

Main menu

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

Nav